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Introduction
Nowadays, orthotopic heart transplantation (OHT) and
orthotopic liver transplantation (OLT) are standardized
and frequent procedures. However, simultaneous com-
bined liver and heart transplantation (CLHT) constitu-
tes a real surgical challenge. Since the first report of
CLHT by Starzl et al. [5], only a few cases have been de-
scribed in the literature, and no standard surgical proce-
dure has been established. We report the case of a young
patient suffering from homozygous beta-thalassemia
who developed end-stage diseases of the liver and the
heart and required CLHT. This procedure was per-
formed with the technique of OLT described by Belghiti
et al. [1], allowing early discontinuation of the bypass
and minimizing the coagulopathy. The advantages of
this technique in CLHT are discussed.
Case report
A 28-year-old male patient suffering from homozygous beta-tha-
lassemia had been treated by weekly transfusions and subcuta-
neous deferoxamine since the age of 9 years. He underwent sple-
nectomy in 1976 and laparoscopic cholecystectomy in 1992. In
1993, he developed cardiac failure; endomyocardial biopsy re-
vealed heavy iron deposits and fibrosis. Despite medical therapy,
the patient experienced several episodes of acute cardiac failure
that required hospitalization for intravenous treatment. In May
1995, cardiac angiography demonstrated congestive cardiomyopa-
thy with a left ventricular ejection fraction of 15%. Deterioration
in hepatic function was evidenced by abnormalities in prothrombin
time. Magnetic resonance imaging of the abdomen revealed mod-
erate ascites and an enlarged liver with hepatic hemosiderosis. A li-
ver biopsy showed heavy iron loading and portal fibrosis with pat-
chy cirrhosis. CLHT was considered as the last therapeutic option
for this young patient. On 25 November 1995, a compatible 20-
year-old organ donor became available. Standard multiple organ
harvesting was performed while the recipient was prepared in an
adjacent operating room. The abdomen and thorax were opened
through a midline incision extending from the manubrium to the
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Abstract Only a few cases of com-
bined liver and heart transplanta-
tion have been reported in the lit-
erature, and no standard surgical
procedure has yet been established.
We report the successful transplan-
tation of both liver and heart in a 28-
year-old patient suffering from
homozygous beta-thalassemia. We
used Belghiti’s technique of inferior
vena caval flow preservation for li-
ver transplantation, which avoids
inferior vena cava occlusion by a
side-to-side caval anastomosis. Ap-
plied to combined liver and heart
transplantation, preservation of ca-
val flow during liver transplantation
may allow early discontinuation of
cardiopulmonary bypass and, thus,
minimize the general consequences
of prolonged bypass.
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dard cardiopulmonary bypass was then instituted with selective
cannulation of both the superior and inferior vena cava and the as-
cending aorta. Standard OHT was then performed. The total is-
chemic time for the heart was 64 min. The patient was rewarmed,
and once function of the new heart was satisfactory, bypass was dis-
continued and anticoagulation was reversed. Hepatectomy and li-
ver transplantation were performed without IVC occlusion, ac-
cording to the technique described by Belghiti et al. [1]. Portal
vein clamping was well tolerated by the intestine, and venous by-
pass was not required. The side-to-side IVC anastomosis was per-
formed without complications. The duration of the anhepatic
phase was 31 min, and the total ischemic time for the liver was
184 min. The total operating time was 8.5 h.
The immediate postoperative course was uneventful, and the
patient was transferred to a regular ward after having spent 3 days
in the intensive care unit. The immunosuppression regimen consis-
ted of triple drug therapy with cyclosporin, corticosteroids, and
azathioprine. In addition, a course of antithymocyte globulin was
given prophylactically in the early post-transplantation period.
Corticosteroid administration was interrupted after 1 month be-
cause of the onset of infectious encephalitis. Nine months after
the CLHT, the patient was asymptomatic, and his cardiac and he-
patic functions were normal.
Discussion
There are very few indications for CLHT: CLHTs have
been reported in patients suffering from familial hy-
percholesterolemia [4, 5], familial amyloidosis [3], or
homozygous beta-thalassemia [2]. In homozygous beta-
thalassemia, CLHT may be the only option for patients
with end-stage, iron-induced, cardiac and liver disease,
and it should be considered for any patient with iron
loading and severe cardiac dysfunction associated with
biopsy-proven cirrhosis [2].
No consensus has emerged regarding the ideal surgi-
cal procedure of CLHT. Shaw et al. [4] described the
first three cases of CLHT in 1985. In these cases, cardio-
pulmonary bypass and portal vein decompression by
portal drainage into the pump oxygenator were used
during the liver transplantation. This prolonged bypass
allowed the heart graft support and the reinjection of
blood lost during the OLT. However, it may induce coa-
gulopathy, which is worsened by the heparin required by
the cardiopulmonary bypass. In the cases of Shaw et al.,
the coagulopathy took several hours to reverse. Since
1985, several techniques for recipient IVC preservation
during OLT have been developed. The most famous of
these is the “piggyback” procedure [6], which was mod-
ified by Belghiti et al. [1] in order to preserve the flow
in the recipient IVC during OLT by a side-to-side IVC
anastomosis using partial clamping of the anterior part
of the recipient IVC. This IVC flow preservation redu-
ces the indication of venous bypass in OLT if the recipi-
ent tolerates the partial IVC clamping test before hepa-
tectomy, and it reduces the duration of the anhepatic
phase because it requires only one caval anastomosis
[1].
In our case of CHLT, we transplanted the liver with
Belghiti’s technique of OLTafter discontining the cardi-
opulmonary bypass. The ischemic time for the heart
graft was minimal and its function was immediately ex-
cellent, so that minimal inotropic support was required.
The portal and caval clamping was well tolerated by
the transplanted heart, even after the removal of the
cardiopulmonary bypass. As a matter of fact, this heart
graft function may be the limiting factor in the bypass
removal in CLHT. In cases of prolonged ischemic time
for the heart graft or of relative right heart insufficiency
in the immediate post-OHT period, the partial IVC
clamping may not be hemodynamically tolerated by
the transplanted heart. The use of cardiopulmonary by-
pass as a cardiac support may then be useful in OLT if
the recipient is unstable after OHT.
This case demonstrates that in CLHT, the technique
of IVC flow preservation described by Belghiti and cow-
orkers is feasible. It may allow the early discontinuation
of the cardiopulmonary bypass, reducing the surgical
time and the serious complications of prolonged bypass.
However, the exact value and indications of this techni-
que in CLHT should be evaluated by subsequent cases.
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